Market Cap 6.02B
Revenue (ttm) 3.39B
Net Income (ttm) 357.79M
EPS (ttm) N/A
PE Ratio 18.96
Forward PE 17.56
Profit Margin 10.55%
Debt to Equity Ratio 0.07
Volume 381,400
Avg Vol 350,462
Day's Range N/A - N/A
Shares Out 629.48M
Stochastic %K 95%
Beta 1.14
Analysts Strong Sell
Price Target N/A

Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene te...

Industry: Medical Devices
Sector: Healthcare
Phone: 81 78 265 0500
Address:
1-5-1 Wakihama Kaigandori, Chuo-ku, Kobe, Japan
Latest News on SSMXY
No data available.